Sources of uncertainty originate from the panoply of glycemic targets, the complexity of drug therapy, the choice of the first drug, the ideal sequence of drugs after the first drug failure, the possible harms of anti-hyperglycemic drugs, the outcomes of treatment (surrogate versus clinical) and the hierarchy of risk factors to treat for preventing the vascular complications
The practical implication: your provider can write the most compelling medical necessity letter in the world, but if your employer excluded weight-loss medications in step 1, the letter is irrelevant
"I didn't even realize I had such disordered eating until I started this medication," Steward said
Front Pharmacol (2020) 11:343
nigra -induced oxidative stress
This diversity is critical for understanding how retatrutide performs across different populations